Respiratory syncytial virus: can we still believe that after pandemic bronchiolitis is not a critical issue for public health?
Authors:
- Anna Chiara VittucciAVAnna Chiara Vittucci
- Livia AntiliciLALivia Antilici
- Cristina RussoCRCristina Russo
- Anna Maria Caterina MusolinoAMAnna Maria Caterina Musolino
- Sebastian CristaldiSCSebastian Cristaldi
- Renato CutreraRCRenato Cutrera
- Massimiliano RaponiMRMassimiliano Raponi
- Carlo Federico PernoCPCarlo Federico Perno
- Alberto VillaniAVAlberto Villani
Open Access
- 20 September 2023
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 182 (12) , 5303-5313
Abstract
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection among infants and young children, resulting in annual epidemics worldwide. Since the beginning of the COVID-19 pandemic, non-pharmacological interventions were applied, interfering with the circulation of most respiratory viruses, including RSV. The aim of this study is to analyze the RSV infection trend among hospitalized infants during the actual epidemic season (2022–2023) in comparison with the last pre-pandemic season (2018–2019), in order to outline whether significant differences emerge due to COVID-19 pandemia. We retrospectively reviewed medical data on infants hospitalized at the Bambino Gesù Children’s Hospital with diagnosis of bronchiolitis in the current epidemic season and in the last pre-pandemic season, 2018–2019. RSV remains the main etiological agent of bronchiolitis in terms of frequency and severity of infections in the ongoing epidemic season. The first RSV case of the 2022–2023 season was detected at week 42 vs week 47 in the 2018–2019 season. The length of epidemic season was of 17 weeks in 2022–2023 vs 18 weeks in 2018–2019. Comparing the two seasons, age at admission was significantly higher in the current season (median age 2022–2023 65 days vs median age 2018–2019 58 days), but the disease severity was similar. Conclusions: The 2022–2023 bronchiolitis season in Italy started earlier than the usual pre-pandemic seasons but seasonality pattern may be going back to the pre-pandemic one. This season was not more severe than the previous ones. The impact of RSV disease on health care systems and costs remains a critical issue. What is Known:• RSV is one of the major leading causes of hospitalization among children aged less than 3 months. SarsCOV2 pandemic interfered with the seasonal circulation of most respiratory viruses, Including RSV. What is New:• The 2022–2023 bronchiolitis season in Italy started and peaked earlier than the usual pre-pandemic seasons but seasonality pattern may be realigning to the pre-pandemic one. The impact of RSV disease on health care systems and costs is concerning.Keywords
This publication has 42 references indexed in Scilit:
- Respiratory Syncytial Virus–Associated Hospitalizations Among Young Children: 2015–2016Pediatrics, 2020
- Increased Detection of Viruses in Children with Respiratory Tract Infection Using PCRInternational Journal of Environmental Research and Public Health, 2020
- Respiratory Syncityal Virus A and B: three bronchiolitis seasons in a third level hospital in ItalyItalian Journal of Pediatrics, 2019
- High-flow nasal cannula therapy for children with bronchiolitis: a systematic review and meta-analysisArchives of Disease in Childhood, 2019
- Seasonality and geographical spread of respiratory syncytial virus epidemics in 15 European countries, 2010 to 2016Eurosurveillance, 2018
- Clinical Profiles of Respiratory Syncytial Virus Subtypes A AND B Among Children Hospitalized with BronchiolitisThe Pediatric Infectious Disease Journal, 2017
- Viral bronchiolitisThe Lancet, 2017
- Bronchiolitis: Analysis of 10 consecutive epidemic seasonsPediatric Pulmonology, 2016
- WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015Vaccine, 2016
- The Burden of Respiratory Syncytial Virus Infection in Young ChildrenNew England Journal of Medicine, 2009